Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review.
Klinicka onkologie · 2024
DOI: 10.48095/ccko2024354 ↗Kurz gefasst
Fallbericht in der Zeitschrift Klinicka onkologie, 2024. Verfasst von A Čermák und 16 weiteren Autor:innen. Hauptthemen laut MEDLINE: Retroperitoneal Fibrosis, Rituximab, Cyclophosphamide, Dexamethasone.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Čermák, A., Foukal, J., Řehák, Z., Adam, Z., Keřkovský, M., Hruška, L., Borský, M., Doubek, M., Vlažný, J., Pavlovský, Z., Chovancová, Z., Boichuk, I., Štork, M., Pour, L., Koukalová, R., Tomíška, M., & Král, Z. (2024). Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review. Klinicka onkologie. https://doi.org/10.48095/ccko2024354
Vancouver
Čermák A, Foukal J, Řehák Z, Adam Z, Keřkovský M, Hruška L, et al. Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review. Klinicka onkologie. 2024. doi:10.48095/ccko2024354
BibTeX
@article{ermk2024,
author = {Čermák, A and Foukal, J and Řehák, Z and Adam, Z and Keřkovský, M and Hruška, L and Borský, M and Doubek, M and Vlažný, J and Pavlovský, Z and Chovancová, Z and Boichuk, I and Štork, M and Pour, L and Koukalová, R and Tomíška, M and Král, Z},
title = {Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review},
journal = {Klinicka onkologie},
year = {2024},
doi = {10.48095/ccko2024354}
}
EUVIMED